The global life science & analytical instruments market is on a remarkable growth trajectory, valued at USD 56.56 billion in 2024, growing to USD 59.98 billion in 2025, and projected to reach USD 101.31 billion by 2034. With a steady CAGR of 6.04% from 2025 to 2034, this market is fueled by increasing R&D spending, technological innovations, and growing applications in pharmaceuticals, biotechnology, and healthcare diagnostics.
The growing prevalence of genetic disorders and chronic diseases, combined with robust investments in life sciences research, are key drivers of this market. Technologies such as immunoassays, chromatography, spectroscopy, flow cytometry, PCR, next-generation sequencing (NGS), and clinical chemistry analyzers are witnessing surging demand.
2024 Market Size: USD 56.56 billion
2034 Projection: USD 101.31 billion
CAGR (2025–2034): 6.04%
Dominant Region: North America (39% market share in 2024)
Fastest Growing Region: Asia Pacific
Top Product Segment: Spectroscopy instruments (28% revenue share in 2024)
Fastest Growing Product Segment: Lab automation & robotics
Top Application Segment: Pharmaceutical & biotechnology research (46% share in 2024)
About: A global leader in scientific instrumentation, reagents, and consumables.
Products: Chromatography systems, mass spectrometry, genetic analyzers, lab automation.
Market Cap: Approx. USD 225 billion.
About: Focuses on life sciences, diagnostics, and applied chemical markets.
Products: Chromatography, spectroscopy, and molecular biology tools.
Market Cap: Approx. USD 40 billion.
About: Operates across life sciences, diagnostics, and environmental sectors.
Products: Mass spectrometry (Sciex), flow cytometry (Beckman Coulter), microscopy systems (Leica).
Market Cap: Approx. USD 190 billion.
Request a customized case study tailored to your business needs and gain deeper insights
into healthcare market strategies: sales@towardshealthcare.com
About: Japanese company renowned for analytical and measuring instruments.
Products: Chromatography, spectroscopy, and testing machines.
Market Cap: Approx. USD 10 billion.
About: Offers solutions in diagnostics, life sciences, and applied markets.
Products: Genomics, imaging, spectroscopy, and detection technologies.
Market Cap: Approx. USD 15 billion.
About: Specializes in chromatography, mass spectrometry, and thermal analysis.
Products: HPLC systems, UPLC, and analytical software.
Market Cap: Approx. USD 20 billion.
About: Provides high-performance scientific instruments and solutions.
Products: NMR, mass spectrometry, and infrared spectroscopy.
Market Cap: Approx. USD 9 billion.
About: Focuses on life science research and clinical diagnostics.
Products: PCR systems, flow cytometry, and electrophoresis.
Market Cap: Approx. USD 12 billion.
About: A leader in DNA sequencing and array-based technologies.
Products: Next-generation sequencing platforms and reagents.
Market Cap: Approx. USD 25 billion.
About: Develops sample and assay technologies for molecular diagnostics.
Products: PCR, NGS, and automated testing systems.
Market Cap: Approx. USD 10 billion.
About: A division of Roche, leading in in-vitro diagnostics solutions.
Products: Molecular diagnostics, clinical chemistry, and immunoassays.
Market Cap (Roche Group): Approx. USD 250 billion.
About: Known for its laboratory instruments and consumables.
Products: Pipettes, centrifuges, and bioprocess equipment.
Market Cap (Private Company): Estimated multi-billion USD turnover.
About: Offers lab materials, technologies, and services for life sciences.
Products: Lab chemicals, reagents, filtration systems.
Market Cap: Approx. USD 80 billion.
About: Provides bioprocessing solutions for pharmaceutical manufacturing.
Products: Bioreactors, chromatography systems, and cell therapy tools.
Market Cap: Approx. USD 35 billion.
About: Supplies high-tech tools for research and industrial applications.
Products: Cryogenic systems, microscopy, and spectroscopy instruments.
Market Cap: Approx. USD 2 billion.
The growth is driven by increasing R&D spending, prevalence of chronic and genetic diseases, and technological advancements in analytical tools.
North America dominates with 39% market share in 2024, while Asia Pacific is expected to grow the fastest.
Spectroscopy instruments lead with a 28% revenue share, while lab automation & robotics are projected to grow fastest.
Major players include Thermo Fisher Scientific, Agilent Technologies, Danaher Corporation, Shimadzu Corporation, and Illumina, among others.
The market is expected to grow at a CAGR of 6.04% between 2025 and 2034.
Source : https://www.towardshealthcare.com/insights/life-science-and-analytical-instruments-market-sizing
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5874
The global digital health and wellness market is projected to expand from US$ 498.99 billion in 2024 to US$ 3,568.11… Read More
The global radiopharmaceutical market is projected to grow from USD 6.8 billion in 2024 to USD 14.11 billion by 2034,… Read More
The U.S. life science market is on an upward trajectory, poised to generate substantial revenue growth, potentially climbing into the… Read More
The U.S. cell therapy market size is forecast to grow at a CAGR of 21.46%, from USD 8.04 billion in… Read More
The global animal biotechnology market was USD 28.17 billion in 2024, rose to USD 30.97 billion in 2025, and is… Read More
The global ophthalmology devices market was US$ 7.51 billion in 2024, rose to US$ 7.89 billion in 2025, and is… Read More